The First Topical Novel Chemical Entity for Adults with Plaque Psoriasis in 25 Years

September 20, 2022

Dermavant CEO Todd Zavodnick joins host Lauren Miller, MPAS, PA-C, to discuss the company’s successful development and FDA approval of VTAMA (tapinarof) cream, 1%, a new topical treatment for plaque psoriasis in adults. In this informative video interview, the two dermatology professionals engage in a conversation about helping to improve patient care through safe, efficacious products that are convenient and accessible.